HC Wainwright reiterated their buy rating on shares of Calumet Specialty Products Partners (NASDAQ:CLMT - Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $33.00 price target on the oil and gas company's stock.
Other equities research analysts have also issued reports about the stock. TD Cowen cut their target price on shares of Calumet Specialty Products Partners from $27.00 to $26.00 and set a "buy" rating on the stock in a report on Monday, November 11th. UBS Group cut shares of Calumet Specialty Products Partners from a "neutral" rating to a "sell" rating and cut their price objective for the company from $20.50 to $15.00 in a research report on Tuesday, February 4th. StockNews.com raised shares of Calumet Specialty Products Partners to a "sell" rating in a research note on Monday, November 18th. Finally, Wells Fargo & Company lifted their target price on Calumet Specialty Products Partners from $25.00 to $29.00 and gave the company an "overweight" rating in a research report on Monday, October 21st. Two research analysts have rated the stock with a sell rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $23.60.
Check Out Our Latest Report on Calumet Specialty Products Partners
Calumet Specialty Products Partners Stock Up 0.1 %
NASDAQ CLMT traded up $0.02 on Wednesday, reaching $16.57. The company had a trading volume of 641,924 shares, compared to its average volume of 1,549,286. Calumet Specialty Products Partners has a 52 week low of $9.97 and a 52 week high of $25.29. The stock has a market cap of $1.42 billion, a price-to-earnings ratio of -6.00 and a beta of 1.88. The stock's 50 day moving average is $19.27 and its 200-day moving average is $19.05.
Insider Buying and Selling
In other Calumet Specialty Products Partners news, Director Jennifer Straumins sold 37,861 shares of the firm's stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $21.42, for a total transaction of $810,982.62. Following the completion of the transaction, the director now owns 1,184,589 shares in the company, valued at approximately $25,373,896.38. This trade represents a 3.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.91% of the stock is currently owned by insiders.
Calumet Specialty Products Partners Company Profile
(
Get Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
See Also
Before you consider Calumet Specialty Products Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.
While Calumet Specialty Products Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
